Beam Therapeutics (BEAM)
(Delayed Data from NSDQ)
$23.47 USD
-0.09 (-0.38%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $23.46 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -1.45 |
EPS Last Quarter | 1.73 |
Last EPS Surprise | 250.43% |
ABR | 1.93 |
Earnings ESP
|
10.77% |
---|---|
Current Year | -5.53 |
Next Year | -5.04 |
EPS (TTM) | -1.90 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 13.67M | 13.67M | 62.24M | 59.09M |
# of Estimates | 5 | 5 | 6 | 5 |
High Estimate | 20.12M | 20.12M | 100.00M | 80.46M |
Low Estimate | 5.00M | 5.00M | 20.00M | 20.00M |
Year ago Sales | 24.21M | 20.12M | 377.71M | 62.24M |
Year over Year Growth Est. | -43.52% | -32.04% | -83.52% | -5.06% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.45 | -1.44 | -5.53 | -5.04 |
# of Estimates | 7 | 6 | 8 | 6 |
Most Recent Consensus | -1.31 | -1.24 | -4.96 | -5.27 |
High Estimate | -1.18 | -1.18 | -4.72 | -4.43 |
Low Estimate | -2.16 | -2.19 | -8.85 | -5.47 |
Year ago EPS | -1.33 | -1.08 | -1.72 | -5.53 |
Year over Year Growth Est. | -9.02% | -33.33% | -221.51% | 8.82% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 6 | 6 | 7 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.45 | -1.44 | -5.53 | -5.04 |
7 Days Ago | -1.45 | -1.44 | -5.53 | -5.04 |
30 Days Ago | -1.44 | -1.43 | -5.50 | -5.06 |
60 Days Ago | -1.10 | -1.10 | -4.54 | -5.36 |
90 Days Ago | -1.09 | -1.09 | -4.42 | -5.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.29 | -1.24 | -5.14 | -5.37 |
Zacks Consensus Estimate | -1.45 | -1.44 | -5.53 | -5.04 |
Earnings ESP | 10.77% | 13.99% | 6.99% | -6.58% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.73 | -1.22 | -1.08 | -1.33 | NA |
Estimate | -1.15 | -1.37 | -1.38 | -1.36 | NA |
Difference | 2.88 | 0.15 | 0.30 | 0.03 | 0.84 |
Surprise | 250.43% | 10.95% | 21.74% | 2.21% | 71.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more